• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有肝细胞癌的肝硬化中视网膜母细胞瘤基因杂合性缺失

Loss of heterozygosity of the retinoblastoma gene in liver cirrhosis accompanying hepatocellular carcinoma.

作者信息

Ashida K, Kishimoto Y, Nakamoto K, Wada K, Shiota G, Hirooka Y, Kamisaki Y, Itoh T, Kawasaki H

机构信息

Department of Clinical Pharmacology, Faculty of Medicine, Tottori University, Yonago, Japan.

出版信息

J Cancer Res Clin Oncol. 1997;123(9):489-95. doi: 10.1007/BF01192203.

DOI:10.1007/BF01192203
PMID:9341898
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12201776/
Abstract

Carcinogenesis is a multistep process. Most hepatocellular carcinoma (HCC) is preceded by liver cirrhosis, but the genetic changes involved in cirrhosis are not known well. The present study was conducted to evaluate aberration of the retinoblastoma (RB) gene in HCC and adjacent non-tumorous liver using 22 patients with chronic liver damage accompanying HCC. The specimens obtained by microdissection from paraffin-embedded tissues were analyzed using an assay based on the polymerase chain reaction for highly polymorphic nucleotide sequences of microsatellites in the RB gene. Out of 22 cases, 15 showed constitutional heterozygosity for the microsatellite markers. In 11 (73.3%) of these 15 informative cases, the primary HCC foci showed loss of heterozygosity (LOH). In 8 of these 11 doubly informative (informative and LOH-positive in primary HCC) cases, LOH was found in 20 (64.5%) of 31 microdissected non-tumorous foci. All of the non-tumorous foci showing RB loss were cirrhotic lesions but there were no foci of chronic hepatitis. The remaining 4 cases without LOH in HCC foci showed no LOH in non-tumorous lesions. In our study, LOH of the RB gene was frequently observed in liver cirrhosis surrounding tumor.

摘要

致癌作用是一个多步骤过程。大多数肝细胞癌(HCC)之前都有肝硬化,但肝硬化所涉及的基因变化尚不清楚。本研究旨在利用22例伴有HCC的慢性肝损伤患者,评估HCC及癌旁非肿瘤性肝组织中视网膜母细胞瘤(RB)基因的畸变情况。使用基于聚合酶链反应的方法,对从石蜡包埋组织中显微切割获得的标本进行RB基因微卫星高度多态性核苷酸序列分析。在22例病例中,15例显示微卫星标记的构成性杂合性。在这15例信息性病例中的11例(73.3%)中,原发性HCC病灶显示杂合性缺失(LOH)。在这11例双重信息性(原发性HCC中信息性且LOH阳性)病例中的8例中,在31个显微切割的非肿瘤病灶中的20个(64.5%)发现了LOH。所有显示RB缺失的非肿瘤病灶均为肝硬化病变,但无慢性肝炎病灶。其余4例HCC病灶无LOH的病例,其非肿瘤性病变也未显示LOH。在我们的研究中,肿瘤周围的肝硬化组织中经常观察到RB基因的LOH。

相似文献

1
Loss of heterozygosity of the retinoblastoma gene in liver cirrhosis accompanying hepatocellular carcinoma.伴有肝细胞癌的肝硬化中视网膜母细胞瘤基因杂合性缺失
J Cancer Res Clin Oncol. 1997;123(9):489-95. doi: 10.1007/BF01192203.
2
Frequent loss in chromosome 8p loci in liver cirrhosis accompanying hepatocellular carcinoma.在伴有肝细胞癌的肝硬化中,8号染色体短臂位点频繁缺失。
J Cancer Res Clin Oncol. 1996;122(10):585-9. doi: 10.1007/BF01221189.
3
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.染色体臂 1p 和 19q 缺失的检测在胶质瘤患者中的诊断准确性和成本效益。
Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD013387. doi: 10.1002/14651858.CD013387.pub2.
4
Loss of the tumor suppressor p53 gene at the liver cirrhosis stage in Japanese patients with hepatocellular carcinoma.日本肝细胞癌患者肝硬化阶段肿瘤抑制基因p53的缺失。
Oncology. 1997 Jul-Aug;54(4):304-10. doi: 10.1159/000227708.
5
Overexpression of E2F1 associated with LOH at RB locus and hyperphosphorylation of RB in non-small cell lung carcinoma.在非小细胞肺癌中,E2F1的过表达与RB基因座的杂合性缺失及RB的过度磷酸化相关。
J Cancer Res Clin Oncol. 2004 Jun;130(6):320-6. doi: 10.1007/s00432-003-0538-3. Epub 2004 Mar 3.
6
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
7
Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis.超声造影使用声诺维®(六氟化硫微泡)与对比增强计算机断层扫描和对比增强磁共振成像在局灶性肝脏病变的特征描述和肝转移检测中的比较:系统评价和成本效益分析。
Health Technol Assess. 2013 Apr;17(16):1-243. doi: 10.3310/hta17160.
8
Evaluation of genetic instability of short tandem repeats in hepatocellular carcinoma.肝细胞癌中短串联重复序列的遗传不稳定性评估
Sci Rep. 2025 Jul 2;15(1):23303. doi: 10.1038/s41598-025-06507-7.
9
MDM2 amplification and loss of heterozygosity at Rb and p53 genes: no simultaneous alterations in the oncogenesis of liposarcomas.MDM2基因扩增以及Rb和p53基因杂合性缺失:在脂肪肉瘤的肿瘤发生过程中无同时性改变。
J Cancer Res Clin Oncol. 1998;124(10):532-40. doi: 10.1007/s004320050211.
10
Magnetic resonance imaging for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.磁共振成像在慢性肝病成人肝细胞癌诊断中的应用。
Cochrane Database Syst Rev. 2022 May 6;5(5):CD014798. doi: 10.1002/14651858.CD014798.pub2.

引用本文的文献

1
MRPS31 loss is a key driver of mitochondrial deregulation and hepatocellular carcinoma aggressiveness.MRPS31 的缺失是导致线粒体失调和肝细胞癌侵袭性的关键驱动因素。
Cell Death Dis. 2021 Nov 12;12(11):1076. doi: 10.1038/s41419-021-04370-8.
2
Dietary fat/cholesterol-sensitive PKCβ-RB signaling: Potential role in NASH/HCC axis.饮食脂肪/胆固醇敏感的蛋白激酶Cβ-调节亚基信号传导:在非酒精性脂肪性肝炎/肝癌轴中的潜在作用。
Oncotarget. 2017 May 15;8(43):73757-73765. doi: 10.18632/oncotarget.17890. eCollection 2017 Sep 26.
3
Repression of Ah receptor and induction of transforming growth factor-beta genes in DEN-induced mouse liver tumors.二乙基亚硝胺诱导的小鼠肝肿瘤中芳烃受体的抑制及转化生长因子-β基因的诱导
Toxicology. 2008 Apr 18;246(2-3):242-7. doi: 10.1016/j.tox.2008.01.002. Epub 2008 Jan 16.
4
Immunohistochemical analysis of p53, cyclinD1, RB1, c-fos and N-ras gene expression in hepatocellular carcinoma in Iran.伊朗肝细胞癌中p53、细胞周期蛋白D1、RB1、c-fos和N-ras基因表达的免疫组织化学分析
World J Gastroenterol. 2007 Jan 28;13(4):588-93. doi: 10.3748/wjg.v13.i4.588.
5
Potential role of p53 mutation in chemical hepatocarcinogenesis of rats.p53突变在大鼠化学性肝癌发生中的潜在作用。
World J Gastroenterol. 2004 Jan;10(1):46-52. doi: 10.3748/wjg.v10.i1.46.
6
Cirrhotic livers reveal genetic changes in the MDM2-P14ARF system of cell cycle regulators.肝硬化肝脏显示出细胞周期调节因子MDM2-P14ARF系统中的基因变化。
Br J Cancer. 2002 Apr 22;86(8):1290-6. doi: 10.1038/sj.bjc.6600238.

本文引用的文献

1
Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies.原发性肝癌:48900例尸检中的100例研究。
Cancer. 1954 May;7(3):462-503. doi: 10.1002/1097-0142(195405)7:3<462::aid-cncr2820070308>3.0.co;2-e.
2
Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4.细胞周期蛋白D与视网膜母细胞瘤基因产物(pRb)的直接结合以及细胞周期蛋白D依赖性激酶CDK4对pRb的磷酸化作用。
Genes Dev. 1993 Mar;7(3):331-42. doi: 10.1101/gad.7.3.331.
3
Tumor progression in hepatocellular carcinoma may be mediated by p53 mutation.肝细胞癌中的肿瘤进展可能由p53突变介导。
Cancer Res. 1993 Jun 15;53(12):2884-7.
4
Frequent loss of heterozygosity on chromosome 22 in hepatocellular carcinoma.肝细胞癌中22号染色体杂合性的频繁缺失。
Hepatology. 1993 May;17(5):794-9.
5
Stemline heterogeneity of nuclear DNA in hepatocellular carcinoma.
Hepatogastroenterology. 1993 Oct;40(5):491-5.
6
Lack of intratumoral heterogeneity in DNA ploidy pattern of hepatocellular carcinoma.肝细胞癌DNA倍体模式中缺乏肿瘤内异质性。
Gastroenterology. 1993 Nov;105(5):1449-54. doi: 10.1016/0016-5085(93)90150-b.
7
Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma.p53基因在肝细胞癌中的作用及突变异质性
Cancer Res. 1993 Jan 15;53(2):368-72.
8
Deletions of chromosome 13q, mutations in Retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma.人类肝细胞癌中13号染色体长臂缺失、视网膜母细胞瘤1基因突变及视网膜母细胞瘤蛋白状态
Cancer Res. 1994 Aug 1;54(15):4177-82.
9
Molecular diagnosis of Prader-Willi syndrome: parent-of-origin dependent methylation sites and non-isotopic detection of (CA)n dinucleotide repeat polymorphisms.普拉德-威利综合征的分子诊断:亲本来源依赖性甲基化位点及(CA)n二核苷酸重复多态性的非同位素检测
Am J Med Genet. 1994 Aug 1;52(1):79-84. doi: 10.1002/ajmg.1320520116.
10
K-ras mutations are a relatively late event in the pathogenesis of lung carcinomas.K-ras基因突变是肺癌发病机制中相对较晚出现的事件。
Cancer Res. 1994 Nov 15;54(22):5811-5.